Overview

Gender

male

Gill has served as our Chief Executive Officer since 2012. Previously he served as President of CME Group since 2007 and as President and Chief Operating Officer of CME Holdings and of CME since January 1, 2004. In addition to running the firm's day-to-day operations, he is responsible for implementing strategic initiatives to expand CME Group's core business and pursue new global growth opportunities in over-the-counter and emerging markets.

From 2000 to 2003, Gill served as Managing Director and President of CME Clearing, the largest derivatives clearing house in the United States, which includes the Clearing, Risk Management and Audit Departments. In 2003, he led the implementation of the company's historic clearing agreement with the Chicago Board of Trade (CBOT), under which CME provided clearing (back-office processing) for all CBOT products. This agreement helped pave the way for the 2007 merger of the two institutions.

Gill joined the company in February 1988 and held positions of increasing responsibility within CME Clearing before joining the Office of the CEO in 2004.Gill serves on CME Group's Board of Directors, as well as the board of the World Federation of Exchanges (WFE) and WFE's Regulatory Policy Committee.

He also serves on the Board of Directors of First Midwest Bancorp Inc. He is a member of CME Group's Competitive Markets Advisory Council and sits on the boards of The Alexander Maxwell Grant Foundation, CME Group Foundation and CME Group Community Foundation.